However, only the AML mouse model with MLL‐AF9 genetic mutation was investigated in this study., e.g. the inconsistent or even opposite results of cytokine expression in AML mice and AML patients, suggesting the presence of potential bias due to different species or genetic background. The gene discussed is KMT2A; the disease is acute myeloid leukemia.